Suva et al. found that IDH-mutant WHO G4 astrocytomas exhibit lower levels of PRMT5 expression compared to IDH-wildtype glioblastoma, suggesting that PRMT5 may be influenced by IDH mutation [21]. This evidence concerns the gene PRMT5 and glioblastoma.